After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
CTMX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of CytomX Therapeutics Inc is $87.49M. A total of 0.84 million shares were traded on the day, compared to an average of 686.63K shares.
In the most recent transaction, Landau Jeffrey B sold 4,181 shares of CTMX for 1.23 per share on Aug 20 ’24. After the transaction, the Chief Business Officer now owns 119,056 company shares. In a previous transaction on Aug 20 ’24, BELVIN MARCIA sold 4,181 shares at 1.23 per share. CTMX shares that SVP, Chief Scientific Officer owns now total 175,648.
Among the insiders who sold shares, ROWLAND LLOYD A disposed of 4,181 shares on Aug 20 ’24 at a per-share price of $1.23. This resulted in the General Counsel holding 130,797 shares of CTMX after the transaction. In another insider transaction, Ogden Christopher sold 1,984 shares at $1.23 per share on Aug 20 ’24. Company shares held by the Chief Financial Officer now total 108,077.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CTMX has a high of $5.85 and a low of $1.04.
As of this writing, CTMX has an earnings estimate of -$0.17 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.09 per share and a lower estimate of -$0.28. The company reported an EPS of $0.04 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CTMX’s latest balance sheet shows that the firm has $305.23M in Cash & Short Term Investments as of fiscal 2021. There were $21.67M in debt and $77.87M in liabilities at the time. Its Book Value Per Share was -$0.40, while its Total Shareholder’s Equity was -$459.00k.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CTMX is Buy with a score of 4.14.
